Singapore: Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based China...
Singapore: Eisai has revealed therapeutic effects of lenvatinib (generic name- VEGF receptor tyrosine kinase inhibitor a...
The product is ready for Day 1 launch, said Strides in a press release. Dutasteride is used to treat benign prostatic h...
Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...
Singapore: Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline...
Singapore: Taiwan's PharmaEngine has filed a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA...
Singapore: AOP Orphan, a pharmaceutical company in the field of rare diseases, has launched world's first drug approved ...
Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...
Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization co...
Singapore: 3SBio, China-based biotechnology company focused on researching, developing, manufacturing and marketing biop...
Singapore: US based Roivant Neurosciences, a biopharmaceutical company engaged in the development and commercialization ...
Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of ...
Bangalore: AstraZeneca and Cellworks have announced a collaboration, to speed the design of novel combination therapies ...
Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repur...
Singapore: Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cance...
‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formotero...
Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza s...
Singapore: Merck's grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis...
